Johnson & Johnson Development Corp, a unit of Johnson & Johnson Inc, has completed the DKK 475 million ($82 million) purchase of 10.7% of the enlarged share capital of Genmab A/S as part of a previously announced collaboration. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
